These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The effect of SARS-CoV-2 on the development of Parkinson's disease: the role of α-synuclein. Iravanpour F; Farrokhi MR; Jafarinia M; Oliaee RT Hum Cell; 2024 Jan; 37(1):1-8. PubMed ID: 37735344 [TBL] [Abstract][Full Text] [Related]
24. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease. Barrenschee M; Zorenkov D; Böttner M; Lange C; Cossais F; Scharf AB; Deuschl G; Schneider SA; Ellrichmann M; Fritscher-Ravens A; Wedel T Acta Neuropathol Commun; 2017 Jan; 5(1):1. PubMed ID: 28057070 [TBL] [Abstract][Full Text] [Related]
25. The central theme of Parkinson's disease: α-synuclein. Ozansoy M; Başak AN Mol Neurobiol; 2013 Apr; 47(2):460-5. PubMed ID: 23180276 [TBL] [Abstract][Full Text] [Related]
26. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Gelpi E; Navarro-Otano J; Tolosa E; Gaig C; Compta Y; Rey MJ; Martí MJ; Hernández I; Valldeoriola F; Reñé R; Ribalta T Mov Disord; 2014 Jul; 29(8):1010-8. PubMed ID: 24395122 [TBL] [Abstract][Full Text] [Related]
27. The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Wakabayashi K; Tanji K; Mori F; Takahashi H Neuropathology; 2007 Oct; 27(5):494-506. PubMed ID: 18018486 [TBL] [Abstract][Full Text] [Related]
28. Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease. Xu S; Chan P Biomolecules; 2015 Jun; 5(2):1122-42. PubMed ID: 26057626 [TBL] [Abstract][Full Text] [Related]
29. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734 [TBL] [Abstract][Full Text] [Related]
31. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208 [TBL] [Abstract][Full Text] [Related]
33. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies]. Orimo S Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627 [TBL] [Abstract][Full Text] [Related]
34. Interaction of LRRK2 and α-Synuclein in Parkinson's Disease. Daher JP Adv Neurobiol; 2017; 14():209-226. PubMed ID: 28353286 [TBL] [Abstract][Full Text] [Related]
35. Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients. Recasens A; Carballo-Carbajal I; Parent A; Bové J; Gelpi E; Tolosa E; Vila M Acta Neuropathol Commun; 2018 Feb; 6(1):8. PubMed ID: 29422109 [TBL] [Abstract][Full Text] [Related]
36. Are Therapies That Target α-Synuclein Effective at Halting Parkinson's Disease Progression? A Systematic Review. Rodger AT; ALNasser M; Carter WG Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446200 [TBL] [Abstract][Full Text] [Related]
37. Non-motor parkinsonian pathology in aging A53T α-synuclein mice is associated with progressive synucleinopathy and altered enzymatic function. Farrell KF; Krishnamachari S; Villanueva E; Lou H; Alerte TN; Peet E; Drolet RE; Perez RG J Neurochem; 2014 Feb; 128(4):536-46. PubMed ID: 24117685 [TBL] [Abstract][Full Text] [Related]
38. Association of Glial Activation and α-Synuclein Pathology in Parkinson's Disease. Wang R; Ren H; Kaznacheyeva E; Lu X; Wang G Neurosci Bull; 2023 Mar; 39(3):479-490. PubMed ID: 36229715 [TBL] [Abstract][Full Text] [Related]
39. α-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson's disease patients. Manne S; Kondru N; Jin H; Anantharam V; Huang X; Kanthasamy A; Kanthasamy AG Mov Disord; 2020 Feb; 35(2):268-278. PubMed ID: 31758740 [TBL] [Abstract][Full Text] [Related]